Consideration of Bragg-Peak-Broadening by heterogeneous Lung Tissue in the Proton Therapy used for treating thoracic Tumors

被引：0
|
作者：
Baumann, K. -S. [1 ,2 ]
Flatten, V. [1 ,2 ]
Weber, U. [3 ]
Lautenschlaeger, S. [1 ]
Eberle, F. [1 ,4 ]
Engenhart-Cabillic, R. [1 ,4 ]
Zink, K. [1 ,2 ,5 ]
机构：
[1] Univ Klinikum Giessen & Marburg, Klin Strahlentherapie & Radioonkol, Marburg, Germany
[2] Tech Hsch Mittelhessen, Inst Med Phys & Strahlenschutz, Giessen, Germany
[3] GSI Helmholtzzentrum Schwerionenforsch, Abt Biophys, Darmstadt, Germany
[4] MIT, Marburg, Germany
[5] FIAS, Frankfurt, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2018年 / 194卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
21-3-jD
引用
收藏
页码：S178 / S179
页数：2
相关论文
共 24 条
  • [1] Consideration of Bragg-Peak Broadening by Heterogeneous Lung Tissue in the Proton Therapy of Thoracic Tumors
    Baumann, K. -S
    Flatten, V
    Weber, U.
    Lautenschlaeger, S.
    Eberle, F.
    Zink, K.
    Engenhart-Cabillic, R.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S141 - S141
  • [2] Quantification of the Dose Uncertainties due to the Bragg Peak-Broadening through heterogeneous Lung Tissue in the Proton Therapy of Patients with Thoracic Tumors
    Baumann, K-S
    Flatten, V.
    Weber, U.
    Witt, M.
    Eberle, F.
    Lautenschlaeger, S.
    Zink, K.
    Engenhart-Cabillic, R.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) : S230 - S231
  • [3] Assessment and Quantification of the Dependency of Bragg-Peak Broadening by Lung Tissue in Proton Therapy
    Flatten, V
    Baumann, K. -S
    Weber, U.
    Lautenschlaeger, S.
    Eberle, F.
    Zink, K.
    Engenhart-Cabillic, R.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S178 - S178
  • [4] Effects of the Bragg peak degradation due to lung tissue in proton therapy of lung cancer patients
    Baumann, Kilian-Simon
    Flatten, Veronika
    Weber, Uli
    Lautenschlaeger, Stefan
    Eberle, Fabian
    Zink, Klemens
    Engenhart-Cabillic, Rita
    RADIATION ONCOLOGY, 2019, 14 (01)
  • [5] Effects of the Bragg peak degradation due to lung tissue in proton therapy of lung cancer patients
    Kilian-Simon Baumann
    Veronika Flatten
    Uli Weber
    Stefan Lautenschläger
    Fabian Eberle
    Klemens Zink
    Rita Engenhart-Cabillic
    Radiation Oncology, 14
  • [6] Correction to: Effects of the Bragg peak degradation due to lung tissue in proton therapy of lung cancer patients
    Kilian-Simon Baumann
    Veronika Flatten
    Uli Weber
    Stefan Lautenschläger
    Fabian Eberle
    Klemens Zink
    Rita Engenhart-Cabillic
    Radiation Oncology, 15
  • [7] Quantification of the dependencies of the Bragg peak degradation due to lung tissue in proton therapy on a CT-based lung tumor phantom
    Flatten, Veronika
    Baumann, Kilian-Simon
    Weber, Uli
    Engenhart-Cabillic, Rita
    Zink, Klemens
    PHYSICS IN MEDICINE AND BIOLOGY, 2019, 64 (15):
  • [8] Effects of the Bragg peak degradation due to lung tissue in proton therapy of lung cancer patients (vol 14, 183, 2019)
    Baumann, Kilian-Simon
    Flatten, Veronika
    Weber, Uli
    Lautenschlaeger, Stefan
    Eberle, Fabian
    Zink, Klemens
    Engenhart-Cabillic, Rita
    RADIATION ONCOLOGY, 2020, 15 (01)
  • [9] Does Proton Therapy Offer Demonstrable Clinical Advantages for Treating Thoracic Tumors?
    Liao, Zhongxing
    Gandhi, Saumil J.
    Lin, Steven H.
    Bradley, Jeffrey
    SEMINARS IN RADIATION ONCOLOGY, 2018, 28 (02) : 114 - 124
  • [10] Methodology and Data for Considering the Bragg Peak Propagation in the Irradiation of Lung Tumors in the Particle Therapy
    Flatten, V.
    Baumann, K-S
    Weber, U.
    Zink, K.
    Engenhart-Cabillic, R.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2022, 198 (SUPPL 1) : S185 - S185
123